Skip to main content
. Author manuscript; available in PMC: 2022 Feb 17.
Published in final edited form as: Pediatrics. 2019 Jul 12;144(2):e20183457. doi: 10.1542/peds.2018-3457

TABLE 2.

The Clinical Significance of Treatment Results Expressed as RRs for Decrease in BMI z Score Using the Cutoffs 0.25 and 0.5

Group Decrease in BMI z Score ≥0.25,
RR (95% CI)
Decrease in BMI z Score ≥0.5,
RR (95% CI)>
3-mo follow-up
 Booster 1.4 (1.2 to 1.5)** 1.5 (1.2 to 1.8)**
 No Booster 1.2 (1.1 to 1.4)* 1.1 (0.9 to 1.4)
6-mo follow-up
 Booster 1.8 (1.4 to 2.4)** 2.2 (1.6 to 3.1)**
 No Booster 1.5 (1.1 to 2.0)* 1.3 (0.8 to 2.0)
12-mo follow-up
 Booster 3.3 (2.0 to 5.6)** 4.8 (2.4 to 9.6)**
 No Booster 2.3 (1.3 to 3.9)* 1.6 (0.6 to 4.0)

ST was used as a reference in all calculations.

*

P < .01

**

P < .001.